Epic Research

Monday, July 8, 2013

Epic Update : Fresenius Kabi

Receives warning letter from US FDA for API plant at Kalyani, India
Warnings related to Good Manufacturing Practices (GMP) non-conformities regarding manufacturing
US FDA warnings related to documentation practices
US FDA warnings related to data integrity
Will respond comprehensively to the warning letter
’13 guidance incl expected 1-time charge to remediate issue. - See more at: http://www.epicresearch.co/blog/#sthash.teHjOhqu.dpuf

Epic Update Fresenius Kabi OncologyReceives warning letter from US FDA for API plant at Kalyani, India
Warnings related to Good Manufacturing Practices (GMP) non-conformities regarding manufacturing
US FDA warnings related to documentation practices
US FDA warnings related to data integrity
Will respond comprehensively to the warning letter
’13 guidance incl expected 1-time charge to remediate issue. 
 

Get Free MCX TipsStock TipsForex Tips & NCDEX Tips,Commodity TipsShare Tipscommodity tips free trialnifty free tipscommodity trading tipsshares tipsShare Market TipsStock Market Tipsfree stock tips on mobileStock trading tipsIntraday Tips. or login http://www.epicresearch.co/

No comments:

Post a Comment